Last reviewed · How we verify

NCT05519163

A Study on Predictive Model for New-onset Diabetic Foot in Type 2 Diabetes Patients.

Completed Last updated 26 April 2024
What this trial tests

trial in Diabetic Foot in 6,301 participants. Completed in 31 December 2021.

Timeline
1 January 2016
Primary endpoint
31 December 2021
31 December 2021

Quick facts

Lead sponsorYibing Wang
StatusCompleted
Study typeOBSERVATIONAL
Enrollment6,301
Start date1 January 2016
Primary completion31 December 2021
Estimated completion31 December 2021
Sites1 location across China

Conditions studied

Sponsor

Yibing Wang

Who can join

20 and older, any sex, with Diabetic Foot. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A retrospective cohort study was constructed based on hospitalized patients with type 2 diabetes, aiming to explore the related factors for new-onset diabetic foot and conducted a robust prediction model by Cox proportional hazards model.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Risk factors and a predictive model of diabetic foot in hospitalized patients with type 2 diabetes.
    Li MZ, Tang F, Liu YF, Lao JH, et al · · 2025 · cited 1× · PMID 40093275 · DOI 10.4239/wjd.v16.i3.95644

Verify or expand the search:

Other recruiting trials for Diabetic Foot

Currently open trials in the same condition.

Other Yibing Wang trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05519163.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing